According to cell lysis market outlook, the global cell lysis market will grow at a CAGR of close to 8% during the forecast period. The growing popularity of personalized medicines is one of the key factors driving the growth of this market in the next few years. The development of personalized medicine contributes to the exploration of new therapies for genetic anomalies. Genome mapping studies and the application of whole genome technology is extensively necessary to develop personalized medicines. The process of cell lysis is equally necessary to develop personalized medicine. Cell disruption is carried out to understand the interaction of cells. This helps researchers to develop or alter the structure of drugs to treat diseases. Additionally, the focus of the researchers to come up with new techniques such as reverse phase protein array (RPPA) technology for protein extraction to develop personalized medicine will also drive market growth since this technique involves homogenized cell lysis, which is performed using various methods.
Based on the cell lysis industry insights, one of the key trends that will propel the growth prospects for the cell lysis market during the predicted period is the increasing usage of reagents for cell disruption. The demand for reagents to carry out cell lysis is increasing since the traditional methods of cell lysis are time-consuming. Reagents can be included in any process without any change and they provide results within a short period.
Competitive landscape and key vendors
The cell lysis market is highly competitive due to the presence of many key companies. The leading vendors are focusing on introducing new products and are upgrading their existing products to maintain their market shares. They are also focusing on improving their product portfolios by offering both consumables and instruments. These companies sell their products to end-users such as research laboratories, hospitals, and pharmaceutical and biotechnology companies.
Key vendors in this market are -
Thermo Fisher Scientific
Other prominent vendors in the market include Becton, Dickinson and Company, Cell Signaling Technology, F. Hoffmann–La Roche, Miltenyi Biotec, Omni International, Qiagen, and Qsonica.
Segmentation by end-users and analysis of the cell lysis market
Research laboratories and institutions
Biotechnology and pharmaceutical companies
The demand for cell lysis instruments and consumables is increasing in research laboratories and institutions due to the increasing number of research activities related to molecules and proteins. Cell lysis involves the extraction of different biomolecules from cells. The development of treatments for breast and lung cancers involve the analysis of individual cell components. The demand for lysis instruments and consumables will further increase until the end of 2021 due to the rising research activities related to the breast and lung cancers.
Segmentation by geography and analysis of the cell lysis market
Various universities, academic institutions, and biotechnology companies in the Americas are taking efforts to reduce the prevalence of autoimmune disorders and several types of cancer. This encourages them to increase the number of cell-based research studies, which in turn, will positively influence the cell lysis buffer market during the estimated period.
Key questions answered in the report include
What will the market size and the growth rate be in 2021?
What are the key factors driving the global cell lysis market?
What are the key market trends impacting the growth of the global cell lysis market?
What are the challenges to market growth?
Who are the key vendors in the global cell lysis market?
What are the market opportunities and threats faced by the vendors in the global cell lysis market?
What are the trending factors influencing the market shares of the Americas, APAC, and EMEA?
What are the key outcomes of the five forces analysis of the global cell lysis market?
Technavio also offers customization on reports based on specific client requirement.